Objective
NONALCOHOLIC FATTY LIVER DISEASE, TYPE 2 DIABETES
Academic Editor: Ferdinando Carlo Sasso The aim of study was to evaluate the effect and safety of pioglitazone-metformin combined treatment in the newly diagnosed type 2 diabetes patients with nonalcoholic fatty liver disease. 